STI stirling products limited

Hi all,this is a e-Newsletter from 25. March 2010Stirling Health...

  1. 288 Posts.
    lightbulb Created with Sketch. 7
    Hi all,

    this is a e-Newsletter from 25. March 2010

    Stirling Health Launch
    Pharmaceutical and Healthcare group, Stirling Products Limited (ASX:STI) advises that a number of its early Stirling Health pharmacy range products are already attracting industry as well as media attention.

    The natural arthritis product, Rose Hip Vital, has over the past year featured on several news and media channels and on the Channel 7 Today Tonight Show in Adelaide this week. The multi-award winning Aden and Anais baby range that Stirling Health is introducing into Australian pharmacies is continually featured in the US media and celebrity press.

    Stirling Health is dedicated to supplying Pharmacy with quality products and has plans to progressively expand the range on an ongoing basis building a comprehensive product range over the next two years as point of difference products are included and as formal Therapeutic Goods Administration registrations are completed. These registrations in many cases will often take over a year for final sale approval.

    This business build-up of the Stirling Health business division, is led by ex big pharma national management and sales personnel that the Company has been able to retain and who each have solid proven performance records within the industry.

    For further information see www.stirlingproducts.net www.stirlinghealth.com.au or contact:

    Peter Boonen
    Managing Director
    Stirling Products Limited
    Ph: +61 2 9299 9270
    E: [email protected]

    For all Investor Relations inquiries please contact:
    James Moses
    Mandate Corporate
    Ph: +61 420 991 574
    E: [email protected]
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.